The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Sulfonamide inhibition studies of twoß-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.EBI
Kochi Medical School
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.EBI
Kochi Medical School
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.EBI
Kochi Medical School
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.EBI
Kochi Medical School
Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.EBI
Kochi Medical School
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.EBI
Kochi Medical School
Inhibition studies of theß-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.EBI
Kochi Medical School
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.EBI
Kochi Medical School
Pharmaceutically active pyrazine derivativesBDB
Sentinel Oncology
Benzenesulfonamide compounds and their use as therapeutic agentsBDB
Xenon Pharmaceuticals
Pyridine compoundsBDB
Daiichi Sankyo
Pyrrolopyrrolone derivatives and their use as BET inhibitorsBDB
Novartis